HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Celine Sze Ling Chui Selected Research

Vaccines

5/2024Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in CKD Patients With COVID-19.
4/2024COVID-19 vaccine effectiveness against the Omicron variant of SARS-CoV-2 in multimorbidity: A territory-wide case-control study.
2/2024Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection.
2/2024Risk of carditis among adolescents after extending the interdose intervals of BNT162b2.
12/2023Vaccine Effectiveness of BNT162b2 and CoronaVac Against SARS-CoV-2 Omicron BA.2 in CKD.
12/2023Effectiveness and Respiratory Adverse Events Following Inactivated and mRNA COVID-19 Vaccines in Patients with COPD and Asthma: A Chinese Population-Based Study.
12/2023Effectiveness of BNT162b2 and CoronaVac vaccines in preventing SARS-CoV-2 Omicron infections, hospitalizations, and severe complications in the pediatric population in Hong Kong: a case-control study.
1/2023Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination With BNT162b2 Increased Risk of Bell's Palsy: A Nested Case-Control and Self-Controlled Case Series Study.
1/2023Sex-based differences in risk of ischaemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study.
1/2023Effectiveness of BNT162b2 after extending the primary series dosing interval in children and adolescents aged 5-17.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Celine Sze Ling Chui Research Topics

Disease

34COVID-19
05/2024 - 01/2022
16Infections
05/2024 - 01/2022
6Myocarditis (Carditis)
02/2024 - 01/2022
3Hypothyroidism
03/2024 - 01/2022
3Type 2 Diabetes Mellitus (MODY)
02/2024 - 12/2022
3Cardiovascular Diseases (Cardiovascular Disease)
02/2024 - 11/2022
3Bell Palsy (Bell's Palsy)
01/2023 - 01/2022
2Thyroiditis
03/2024 - 10/2022
2Hyperthyroidism
03/2024 - 10/2022
2Anaphylaxis (Anaphylactic Shock)
01/2022 - 01/2022
1Stroke (Strokes)
02/2024
1Myocardial Infarction
02/2024
1Muscular Diseases (Myopathy)
02/2024
1Heart Failure
02/2024
1Liver Diseases (Liver Disease)
02/2024
1Schizophrenia (Dementia Praecox)
02/2024
1Hypertension (High Blood Pressure)
02/2024
1Asthma (Bronchial Asthma)
12/2023
1Chronic Obstructive Pulmonary Disease (COPD)
12/2023
1Respiratory Tract Diseases (Respiratory Tract Disease)
10/2023
1Nervous System Diseases (Neurological Disorders)
10/2023
1Neoplasms (Cancer)
10/2023
1Hematuria
01/2023
1Proteinuria
01/2023
1Ischemic Stroke
01/2023
1Hemorrhage
01/2023
1Atrial Fibrillation
01/2023
1Embolism (Embolus)
01/2023
1Virus Diseases (Viral Diseases)
12/2022
1Diabetes Complications
12/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2022
1Diabetes Mellitus
11/2022
1Graves Disease (Basedow Disease)
10/2022
1Chronic Renal Insufficiency
10/2022
1Hemorrhagic Stroke
08/2022
1Herpes Zoster
04/2022
1Leukopenia
01/2022
1Neutropenia
01/2022
1Pericarditis
01/2022
1Chronic Disease (Chronic Diseases)
01/2022
1Thrombocytopenia (Thrombopenia)
01/2022
1Thromboembolism
01/2022
1Rheumatoid Arthritis
01/2022
1Arthritis (Polyarthritis)
01/2022

Drug/Important Bio-Agent (IBA)

35BNT162 VaccineIBA
04/2024 - 01/2022
30sinovac COVID-19 vaccineIBA
04/2024 - 01/2022
24VaccinesIBA
05/2024 - 01/2022
19COVID-19 VaccinesIBA
02/2024 - 01/2022
18Messenger RNA (mRNA)IBA
02/2024 - 01/2022
7insulin receptor-related receptor (IRR)IBA
02/2024 - 01/2022
4molnupiravirIBA
05/2024 - 01/2023
4nirmatrelvir and ritonavir drug combinationIBA
05/2024 - 01/2023
3Antiviral Agents (Antivirals)IBA
05/2024 - 01/2023
3N-methyl-valyl-amiclenomycin (BA 2)IBA
12/2022 - 11/2022
2Thyroxine (Levothyroxine)FDA LinkGeneric
03/2024 - 10/2022
1Antithyroid Agents (Antithyroid Drugs)IBA
03/2024
1LDL CholesterolIBA
02/2024
1oxidized low density lipoproteinIBA
02/2024
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2024
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
02/2024
1Antihypertensive Agents (Antihypertensives)IBA
02/2024
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
02/2024
1Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
02/2024
1Angiotensin Receptor AntagonistsIBA
02/2024
1CI 22IBA
10/2023
1Guanosine Diphosphate (GDP)IBA
10/2023
1Metformin (Glucophage)FDA LinkGeneric
01/2023
1Complement System Proteins (Complement)IBA
01/2022
1TroponinIBA
01/2022
1mRNA VaccinesIBA
01/2022

Therapy/Procedure

1Palliative Care (Palliative Therapy)
02/2024
1Therapeutics
02/2024